GlassScriptPhysician profile
Rafael E Carrion
NPI 1588695894
$239,520.92
in general payments reported to CMS, 2019-2025
26 companies · $26K in 2025
The $26K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75K · 2020: $28K · 2021: $12K · 2022: $24K · 2023: $34K · 2024: $41K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $72K · Food and Beverage: $19K · Travel and Lodging: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $71,720.00 |
| Food and Beverage | $18,807.71 |
| Travel and Lodging | $10,639.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $183,488.82 | 2019-2025 | Titan, Speedicath |
| Endo Pharmaceuticals INC. | $36,991.89 | 2019-2023 | Xiaflex |
| Rigicon,INC. | $10,822.95 | 2022-2025 | Rigi10 Malleable Penile Prosthesis, Rigi10, Rigi10 Malleable Penile Prosthesis |
| Boston Scientific Corporation | $4,161.72 | 2019-2025 | Ams 700, Ams 700 Cxr Rte Kit, General - Oncology |
| Endo USA, INC. | $798.15 | 2024-2025 | Xiaflex, Aveed |
| Baxter Healthcare | $760.94 | 2023-2025 | Floseal, Tisseel |
| Procept Biorobotics Corporation | $557.50 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Axonics, INC. | $244.57 | 2022 | |
| Urogen Pharma, INC. | $209.67 | 2022-2025 | |
| Teleflex LLC | $175.09 | 2024 | Urolift |
| Innovation Technologies INC | $169.29 | 2025 | Irrisept |
| Janssen Biotech, INC. | $133.22 | 2024 | Akeega, Erleada |
| Travere Therapeutics, INC. | $122.32 | 2020 | |
| Cook Medical LLC | $120.90 | 2020-2024 | Litho 150 |
| Therapeuticsmd, INC. | $110.42 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $100.00 | 2022-2023 | Tlando, Xyosted |
| Laborie Medical Technologies Corp. | $98.85 | 2023 | |
| Ambu INC. | $93.83 | 2023-2025 | |
| Astellas Pharma US INC | $81.90 | 2019 | |
| Acerus Pharmaceuticals Corporation | $76.43 | 2022 | |
| Dentsply Ih Ab | $73.05 | 2023-2024 | Lofric, Lofric |
| Bayer Healthcare Pharmaceuticals INC. | $49.65 | 2021 | |
| Organogenesis INC. | $24.48 | 2023 | Puraply |
| Becton, Dickinson and Company | $23.96 | 2025 | Magic3 Go Intermittent Urinary Catheter |
| Karl Storz Endoscopy-America | $16.05 | 2019 | |
| Tolmar, INC. | $15.27 | 2025 | Jatenzo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafael Carrion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.